176 related articles for article (PubMed ID: 28208958)
21. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
Akeda K; Kasai Y; Sakakibara T; Matsumine A; Takegami N; Yamada J; Sudo A
Spine (Phila Pa 1976); 2015 May; 40(10):E601-8. PubMed ID: 25955096
[TBL] [Abstract][Full Text] [Related]
22. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
23. Denosumab for the treatment of giant cell tumor of the bone.
Brodowicz T; Hemetsberger M; Windhager R
Future Oncol; 2015; 11(13):1881-94. PubMed ID: 26161925
[TBL] [Abstract][Full Text] [Related]
24. Giant cell tumour of bone: new treatments in development.
López-Pousa A; Martín Broto J; Garrido T; Vázquez J
Clin Transl Oncol; 2015 Jun; 17(6):419-30. PubMed ID: 25617146
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
26. Current indications for denosumab in benign bone tumours.
Imre A; Zoltán S; Miklós S
EFORT Open Rev; 2023 Dec; 8(12):895-905. PubMed ID: 38038377
[TBL] [Abstract][Full Text] [Related]
27. Denosumab: a new treatment option for giant cell tumor of bone.
Lewin J; Thomas D
Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
Rosario M; Takeuchi A; Yamamoto N; Hayashi K; Miwa S; Higuchi T; Abe K; Taniguchi Y; Aiba H; Tanzawa Y; Murakami H; Tsuchiya H
Anticancer Res; 2017 Feb; 37(2):749-754. PubMed ID: 28179326
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.
Marinova VV; Slavchev SA; Patrikov KD; Tsenova PM; Georgiev GP
Folia Med (Plovdiv); 2018 Dec; 60(4):637-640. PubMed ID: 31188771
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
31. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.
Lipplaa A; Dijkstra S; Gelderblom H
Curr Opin Oncol; 2019 Jul; 31(4):329-335. PubMed ID: 30844887
[TBL] [Abstract][Full Text] [Related]
32. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
Kinoshita H; Orita S; Yonemoto T; Ishii T; Iwata S; Kamoda H; Tsukanishi T; Inage K; Abe K; Inoue M; Norimoto M; Umimura T; Fujimoto K; Shiga Y; Kanamoto H; Furuya T; Takahashi K; Ohtori S
J Med Case Rep; 2019 Apr; 13(1):116. PubMed ID: 31023361
[TBL] [Abstract][Full Text] [Related]
33. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
34. A Young Male With an Active Giant Cell Tumor: A Case Report.
Thakur A; Deshpande SV
Cureus; 2022 Oct; 14(10):e30389. PubMed ID: 36407190
[TBL] [Abstract][Full Text] [Related]
35. Giant-cell tumor of bone, anti-RANKL therapy.
Dufresne A; Derbel O; Cassier P; Vaz G; Decouvelaere AV; Blay JY
Bonekey Rep; 2012 Sep; 1():149. PubMed ID: 24363925
[TBL] [Abstract][Full Text] [Related]
36. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
37. Pathological Fractures in Benign Bone Lesions - Diagnosis and Therapy.
Spodeck D; Guder W; Streitbürger A; Dudda M; Podleska LE; Nottrott M; Hardes J
Z Orthop Unfall; 2024 Feb; 162(1):69-78. PubMed ID: 35882354
[TBL] [Abstract][Full Text] [Related]
38. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
von Borstel D; A Taguibao R; A Strle N; E Burns J
Skeletal Radiol; 2017 Apr; 46(4):571-578. PubMed ID: 28188337
[TBL] [Abstract][Full Text] [Related]
39. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
[TBL] [Abstract][Full Text] [Related]
40. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
